Target intelligence / Profile preview

T-cell receptor recognizing Fel d 1–derived epitopes (TCR-Fel d 1)

Target
TCR-Fel d 1
Molecular classification
Receptor, T-cell receptor
01

Overview

The T-cell receptor (TCR) recognizing Fel d 1–derived epitopes is a primary mediator of the allergic immune response to cats. Fel d 1 is a secretoglobin and the dominant allergen in feline dander, recognized by over 90% of cat-allergic individuals (Grönlund et al., 2010). These TCRs, typically found on CD4+ T-helper cells, recognize specific Fel d 1 peptide fragments presented by MHC class II molecules (Archila et al., 2015). This interaction initiates a Th2-biased inflammatory cascade, characterized by the secretion of cytokines like IL-4 and IL-13, which drive IgE production and allergic symptoms (Larche, 2007). Therapeutic interventions, such as peptide-based immuno-therapeutics (e.g., Cat-PAD), target these TCRs by providing short, non-IgE-binding epitopes to induce T-cell anergy or promote regulatory T-cell (Treg) differentiation (Patel et al., 2013). Successful modulation of these TCR-mediated pathways leads to long-term desensitization and reduced clinical reactivity to cat allergens (Worm et al., 2011).

Other names
Fel d 1-specific T-cell receptorCat allergen-specific T-cell receptorT-cell receptor recognizing Felis domesticus allergen 1
02

Mechanism of action

Induction of immunological tolerance through T-cell anergy, deletion, or the promotion of regulatory T-cells (Tregs) following repeated exposure to specific Fel d 1 epitopes (Larche, 2007; Patel et al., 2013).

03

Biological functions

Immune responseAntigen recognitionT-cell activationCytokine productionImmune tolerance induction
04

Disease associations

Cat allergyAllergic rhinitisAsthmaAtopic dermatitis
05

Safety considerations

Systemic allergic reactionsAnaphylaxisLate-phase skin reactionsInjection site reactions
06

Interacting drugs

Cat-PAD (ToleroMune Cat)

2 more in the full profile.

07

Biomarkers

Fel d 1-specific IgEFel d 1-specific IgG4T-cell proliferation indexIL-10 levelsCD154 expression on CD4+ T-cells

Beyond the preview

Go deeper on T-cell receptor recognizing Fel d 1–derived epitopes (TCR-Fel d 1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor recognizing Fel d 1–derived epitopes (TCR-Fel d 1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call